| USD millions | FY2024 | FY2025 | TTM |
|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 |
| Cost of revenue | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 |
| Research & development | 0.0 | 0.0 | — |
| Selling, general & administrative | 0.0 | 0.0 | — |
| Selling & marketing | 0.0 | 0.0 | — |
| Operating expenses | 0.3 | 1.0 | — |
| Operating income | (0.4) | (1.0) | (1.5) |
| Interest expense | 0.0 | 0.0 | 0.0 |
| Interest income | 3.5 | 3.5 | — |
| Other income / expense | 3.8 | 3.5 | — |
| Pre-tax income | 3.4 | 2.6 | 1.2 |
| Income tax | 0.0 | 0.0 | 0.0 |
| Net income | 3.2 | 2.6 | 1.5 |
| Discontinued operations | 0.0 | 0.0 | — |
| Other net income adjustments | 0.0 | 0.0 | — |
| EPS, basic (per share) | 0.21 | 0.24 | 0.10 |
| EPS, diluted (per share) | 0.21 | 0.24 | 0.10 |
| EBITDA | 2.4 | (1.0) | (1.2) |
| Depreciation & amortization | 0.0 | 0.0 | — |
| Weighted average shares (shares) | 11,178,000 | 10,641,286 | — |
| Weighted average diluted shares (shares) | 11,178,000 | 10,641,286 | — |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
TTM ends 2026-06-30 and uses four consecutive reported quarters.
